Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.17MP/E –Yield –
Jupiter Neurosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $21.80K.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.80K | – |
| FY2024 | Dec 31, 2024 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $24.25K | – |
| Q1 FY2026 | Mar 31, 2026 | $18.65K | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
See a number that looks wrong?